Aditxt, Inc. (NASDAQ:ADTX) Sees Large Increase in Short Interest

Aditxt, Inc. (NASDAQ:ADTX) was the recipient of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,160,000 shares, a growth of 1,070.5% from the December 31st total of 99,100 shares. Approximately 8.2% of the company’s stock are short sold. Based on an average daily trading volume, of 5,450,000 shares, the short-interest ratio is currently 0.2 days.

Aditxt Price Performance

Shares of NASDAQ:ADTX traded up $0.01 on Tuesday, reaching $0.12. The company had a trading volume of 9,262,260 shares, compared to its average volume of 46,672,832. Aditxt has a twelve month low of $0.11 and a twelve month high of $218.00. The stock has a 50-day moving average price of $0.24 and a 200 day moving average price of $14.78.

Aditxt Company Profile

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.